about
sameAs
Ascitic microbiota composition is correlated with clinical severity in cirrhosis with portal hypertensionRepublished: Respiratory microbiota: addressing clinical questions, informing clinical practiceA novel microbiota stratification system predicts future exacerbations in bronchiectasisMatrix metalloproteinases vary with airway microbiota composition and lung function in non-cystic fibrosis bronchiectasisDetermining cystic fibrosis-affected lung microbiology: comparison of spontaneous and serially induced sputum samples by use of terminal restriction fragment length polymorphism profiling.Deriving accurate microbiota profiles from human samples with low bacterial content through post-sequencing processing of Illumina MiSeq data.Studying bacteria in respiratory specimens by using conventional and molecular microbiological approachesCombined systems approaches reveal highly plastic responses to antimicrobial peptide challenge in Escherichia coli.Partitioning core and satellite taxa from within cystic fibrosis lung bacterial communitiesPotentially pathogenic airway bacteria and neutrophilic inflammation in treatment resistant severe asthma.Functional divergence in gastrointestinal microbiota in physically-separated genetically identical miceNext-generation sequencing in the analysis of human microbiota: essential considerations for clinical application.Time between collection and storage significantly influences bacterial sequence composition in sputum samples from cystic fibrosis respiratory infectionsLong-term cultivation-independent microbial diversity analysis demonstrates that bacterial communities infecting the adult cystic fibrosis lung show stability and resilience.Three clinically distinct chronic pediatric airway infections share a common core microbiotaInterpreting infective microbiota: the importance of an ecological perspective.Predominant pathogen competition and core microbiota divergence in chronic airway infectionRespiratory microbiota: addressing clinical questions, informing clinical practice.Complexity, temporal stability, and clinical correlates of airway bacterial community composition in primary ciliary dyskinesia.Using bacterial biomarkers to identify early indicators of cystic fibrosis pulmonary exacerbation onsetAscites bacterial burden and immune cell profile are associated with poor clinical outcomes in the absence of overt infection.Adult non-cystic fibrosis bronchiectasis is characterised by airway luminal Th17 pathway activation.The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.Implications of multiple freeze-thawing on respiratory samples for culture-independent analyses.Bacterial diversity in cases of lung infection in cystic fibrosis patients: 16S ribosomal DNA (rDNA) length heterogeneity PCR and 16S rDNA terminal restriction fragment length polymorphism profiling.The microbiome of otitis media with effusion in Indigenous Australian children.Germs and joints: the contribution of the human microbiome to rheumatoid arthritis.Respiratory microbiota resistance and resilience to pulmonary exacerbation and subsequent antimicrobial interventionSample storage conditions significantly influence faecal microbiome profiles.Enhancing the utility of existing antibiotics by targeting bacterial behaviour?From gut dysbiosis to altered brain function and mental illness: mechanisms and pathwaysInflammasome signaling affects anxiety- and depressive-like behavior and gut microbiome compositionCulture-Independent Detection of Nontuberculous Mycobacteria in Clinical Respiratory Samples.Staphylococcus aureus small-colony variants are independently associated with worse lung disease in children with cystic fibrosisStudying bacterial infections through culture-independent approaches.Divergent Relationships between Fecal Microbiota and Metabolome following Distinct Antibiotic-Induced Disruptions.Lung infections in cystic fibrosis: deriving clinical insight from microbial complexity.Inbred Mouse Populations Exhibit Intergenerational Changes in Intestinal Microbiota Composition and Function Following Introduction to a Facility.Novel concepts in evaluating antimicrobial therapy for bacterial lung infections in patients with cystic fibrosis.Molecular detection of CF lung pathogens: current status and future potential.
P50
Q21089749-308D7A6F-0C26-481F-9D5A-D9E483EFFAADQ26797508-D8788D7B-24D4-4FE4-9B4A-9ADA375F6E03Q28235177-2E074DA6-5247-43BA-A5F1-DAD1A8096191Q28256930-AB2BC77B-BCA9-49F9-82ED-57BA5A6D88B7Q30882278-72096309-CAC3-481F-94DF-BAFF324B068EQ30951053-4E2A4C33-81A0-4E42-9564-B72AC8A2F733Q33430526-9650F73A-FFB5-47F9-BA25-F2063F1DFB14Q33553752-B1E64DA2-2101-410A-8C34-B37317D061E8Q33768691-23E74AFD-0370-4C10-9874-59B704BCE649Q33793577-CCC8A5EB-D9E7-48A3-B030-357AF3DDD58DQ33802195-CB0C12D4-075C-41A2-82AA-D10ABDA2646CQ33806208-EE42E393-F8A2-4092-A790-B6DBCB0A5AF3Q34058611-5E3398FB-F43B-4148-BACB-351EB88AEC0EQ34307354-20AC9322-7D3C-46F6-83D4-96CA23049677Q34425654-25F8E55B-8BBE-41C1-8270-DB875007A32DQ34677317-1EA2582A-E4FA-4521-B7AA-39C1D5D4153BQ34760447-9F7966DF-5A4A-4B97-803C-C22E3F97D0ACQ34818539-2192A7C0-4458-4719-84D6-6167D045DBB0Q34997989-CB10D9DC-5CB0-4C0F-9285-14ED557F312AQ35143420-B220B284-7AE2-4B35-9C8F-0217E8B52C75Q35189328-6E87A2F4-451A-4434-B3BA-6BACCA9030F0Q35231255-D277178D-14FC-42DA-9AC7-DD22388B4CD6Q35472705-138B89A9-7915-4472-A528-613B8EDACBC8Q35473563-27A1A65B-C6AE-4073-B4BD-8B9CA8FEBB6AQ35638889-6F37F90D-3B49-4F08-A37B-0156D2A1BFF1Q35728523-F2A21178-91D3-43D6-A7E7-9882CEC73CB2Q35738938-787204F6-59AD-44E4-B8B0-1E74821842F3Q35837327-732DBECC-E279-4207-9F26-2DF0AB6A6103Q35842738-66C2DD8A-39C0-4883-92DA-32CFF131FB75Q35853204-1D812C95-C5B9-4132-8B0E-6A1494479159Q36932850-AE7A4125-CA0C-4C40-BF3D-D56DCD4EF22BQ36932860-841F985E-5BA1-45B1-A425-A1AD78A53399Q37218631-8C437F9C-E693-44DC-8646-4C0891C2E7A9Q37463364-5984B95A-70C5-41F9-B212-D910F843A200Q37531541-44C60755-19A5-4C6E-8573-1F0947D45180Q37633010-E34C52D5-D257-4E07-84CC-99AB6813C54DQ37705435-F8D64DA4-3923-4045-80D6-894161102043Q37747124-C1656B87-C2D7-47D8-8F48-94B0B50B785AQ37903135-F204F004-ED73-47AB-9FB7-9D8EA8E89D28Q38080967-1C04BD9C-76D7-468A-9761-FC018A95A23A
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Geraint B Rogers
@ast
Geraint B Rogers
@en
Geraint B Rogers
@es
Geraint B Rogers
@nl
Geraint B Rogers
@sl
type
label
Geraint B Rogers
@ast
Geraint B Rogers
@en
Geraint B Rogers
@es
Geraint B Rogers
@nl
Geraint B Rogers
@sl
prefLabel
Geraint B Rogers
@ast
Geraint B Rogers
@en
Geraint B Rogers
@es
Geraint B Rogers
@nl
Geraint B Rogers
@sl
P108
P1053
N-1957-2013
P106
P21
P31
P3829
P496
0000-0003-4054-1947